Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pernix Therapeutics Holdings Inc

+ Add to Watchlist

PTX:US

8.3500 USD 0.0100 0.12%

As of 20:10:00 ET on 04/17/2015.

Company Profile for Pernix Therapeutics Holdings Inc (PTX)

Pernix Therapeutics Holdings, Inc. manufactures pharmaceuticals. The Company acquires, develops and markets medications for the pediatric market including treatments for dermatitis, statin-induced ubiquinone deficiency, deficiencies in active cultures due to diet and antibiotics, and upper respiratory conditions.

Contact Information

Pernix Therapeutics Holdings Inc

10 Park Place Suite 201
Morristown, NJ 07960
United States
Phone: 800-793-2145

Key Executives for Pernix Therapeutics Holdings Inc (PTX)

Douglas Drysdale "Doug"Chairman/President/CEOSanjay S PatelChief Financial Officer
Terence S Novak "Terry"Chief Operating OfficerRick ShalabySenior VP:Sales
Tracy S CliffordVP:Accounting/Treasurer/SecyJessica OienVP:Compliance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil